Latest Leadership Changes News

Ovanti Limited announces a strategic leadership change in its US operations to boost its BNPL platform Flote’s commercialisation and prepare for a potential NASDAQ listing via SPAC.

Bapcor Limited reported a statutory loss of $104.8 million for the first half of FY26, alongside an underlying profit in line with guidance. The company announced a $200 million equity raising to strengthen its balance sheet and fund a strategic turnaround.

Lynas Rare Earths Ltd has reported a striking half-year turnaround with a 1260% surge in net profit, underpinned by rising rare earth prices and strategic expansions. The company also completed a major equity raise to fuel its ambitious Towards 2030 growth plan.

Auravelle Metals has appointed seasoned geologist Stephen Biggins as Non-Executive Chair, marking a strategic leadership shift as the company advances its high-grade gold projects in South Australia and Western Australia.

Kip McGrath Education Centres Limited reported a 15.4% rise in profit after tax for the half-year ending December 2025, driven by pricing and operational efficiencies despite a 5% drop in lesson volumes. The company also declared a fully franked interim dividend and completed a share buyback amid leadership changes.

NeuroScientific Biopharmaceuticals reported a $1.7 million loss for the half-year ending December 2025, driven by ongoing R&D investments. The company progressed clinical treatments for Crohn’s disease and glaucoma, alongside key leadership appointments and strategic partnerships.

Nido Education Limited reported a 3.8% increase in revenue to $169.9 million for 2025, while earnings and net profit declined. The company declared a fully franked final dividend of 2.2 cents per share, underscoring its commitment to shareholder returns despite challenging market conditions.

Piche Resources announces the resignation of Managing Director Karilyn Farmer effective April 2026, with seasoned geologist Claudio Devaux appointed as country manager to ensure continuity in exploration activities.

Island Pharmaceuticals reports a 213.8% increase in half-year loss to $4.81 million, driven by strategic acquisition and clinical development investments. The company advances its antiviral portfolio with Galidesivir and ISLA-101, supported by strong US regulatory engagement and a $9 million capital raise.

Vitura Health Limited reported an 8.3% rise in half-year revenues to $67.87 million, driven by medicinal cannabis sales and telehealth services, yet posted a consolidated loss of $986,341 due to margin pressures and increased costs. Leadership changes and strategic investments mark a pivotal phase for the digital health and medicinal cannabis player.

HITIQ Limited reported a $2.9 million loss for the half-year ending December 2025, while making significant strides in international market expansion and strategic partnerships. The company’s capital raising efforts aim to support its transition from technology validation to commercial execution.

ARN Media Limited reported a 10% revenue decline in FY25 alongside a strategic reset focusing on digital transformation and cost savings. Leadership changes and improved cash flow underpin the company’s pivot to a digitally driven entertainment model.